Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 1 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12384753

    17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 12358921

    Antiviral heterocyclic compounds

    Enanta Pharmaceuticals, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  3. US 12297209

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  4. US 12281140

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  5. US 12268694

    Combination pharmaceutical agents as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  6. US 12264159

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  7. US 12162857

    Antiviral compounds

    Enanta Pharmaceuticals, Inc. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  8. US 12145941

    Heterocyclic antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  9. US 12054493

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  10. US 12018017

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  11. US 12011425

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  12. US 11993600

    Saturated spirocyclics as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  13. US 11970502

    Macrocyclic antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  14. US 11958879

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  15. US 11952389

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  16. US 11945830

    Antiviral heterocyclic compounds

    Enanta Pharmaceuticals, Inc. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  17. US 11945824

    Heterocyclic compounds as anti-viral agents

    Enanta Pharmaceuticals, Inc. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  18. US 11919910

    Spiropyrrolidine derived antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  19. US 11912714

    Spiropyrrolidine derived antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  20. US 11912695

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  21. US 11891393

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  22. US 11834436

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  23. US 11760755

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  24. US 11738019

    Substituted heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted